|
6H8C
Structure of the human GABARAPL2 protein in complex with the UBA5 LIR motif
Deposited 2018-08-02
|
Different construct
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
3–116(114 aa)
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 7;298 K;Ionic strength (raw mmCIF value) 100;Pressure AMBIENT
NMR sample composition
0.6 mM [U-99% 13C; U-99% 15N] GABARAPL2, 1.0 mM No Ubiquitin-like modifier-activating enzyme 5 (UBA5) LIR motif, 50 mM No sodium phosphate, 100 mM No sodium chloride, 4.6 mM No sodium azide, 95% H2O/5% D2O | 95% H2O/5% D2O
NMR sample composition
1.0 mM No GABARAPL2, 0.6 mM [U-99% 13C; U-99% 15N] Ubiquitin-like modifier-activating enzyme 5 (UBA5) LIR motif, 50 mM No sodium phosphate, 100 mM No sodium chloride, 4.6 mM No sodium azide, 95% H2O/5% D2O | 95% H2O/5% D2O
|
Resolution not provided
|
|
7LK3
Crystal structure of untwinned human GABARAPL2
Deposited 2021-02-01
|
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–117(117 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;294 K;0.15 M KBr, 30% (w/v) PEG monomethyl ether 2000
|
Resolution 1.90 Å
R-free 0.233
|
|
7LK3
Crystal structure of untwinned human GABARAPL2
Deposited 2021-02-01
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–117(117 aa)
|
Not recorded
|
EDO 1,2-ETHANEDIOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;294 K;0.15 M KBr, 30% (w/v) PEG monomethyl ether 2000
|
Resolution 1.90 Å
R-free 0.233
|
|
7YO8
Crystal structure of fission yeast Hfl1 LIR fused to human GABARAPL2
Deposited 2022-08-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–116(116 aa)
|
Mutation:F28S V29T
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.8;293 K;8% PEG 3000, 0.1 M sodium citrate
|
Resolution 1.80 Å
R-free 0.205
|
|
8Q6Q
Structure of human immunity related GTPase Q in complex with GABARAPL2.
Deposited 2023-08-14
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–117(117 aa)
|
Not recorded
|
CIT CITRIC ACID × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;20 % w/v Polyethylene glycol 3,350, 200 mM di-Ammonium hydrogen citrate; pH 5.0
|
Resolution 1.80 Å
R-free 0.222
|
|
8Q6Q
Structure of human immunity related GTPase Q in complex with GABARAPL2.
Deposited 2023-08-14
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
1–117(117 aa)
|
Not recorded
|
CIT CITRIC ACID × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;20 % w/v Polyethylene glycol 3,350, 200 mM di-Ammonium hydrogen citrate; pH 5.0
|
Resolution 1.80 Å
R-free 0.222
|